Phytoestrogens in FEO may inhibit receptor access under high endogenous estrogen conditions like PCOS (26), while trans-anethole's strong binding to androgen receptors points to its viability as a therapeutic agent for PCOS (21). Here, AR is linked to polycystic ovary syndrome.